Thyrocare Technologies Faces ₹2.03 Crore Tax Demand

Thyrocare Technologies Limited announced on March 28, 2026, that it has received a tax demand notice from the Income Tax Department. The demand totals ₹202.82 lakh, or ₹2.03 crore, for Assessment Year 2024-25.

Tax Demand Details

The Income Tax Department has issued a Notice of Demand to Thyrocare Technologies Limited for ₹202.82 lakh (₹2.03 crore). This assessment pertains to the fiscal period of Assessment Year 2024-25.

Thyrocare's Stance and Financial Impact

The company has stated that this tax demand will not have a material impact on its operations or overall financials. However, the notice represents a potential financial exposure of ₹2.03 crore. This amount could become payable if Thyrocare's contestation efforts are unsuccessful. The company plans to contest the demand, which will require allocating managerial and financial resources to prepare its case and potential appeals.

Past Regulatory Encounters

This is not the first time Thyrocare has faced scrutiny from tax authorities. In the financial year 2016-17, the company received a Rectification Order from the Income Tax Department, Mumbai, demanding ₹5.13 crore. Additionally, in 2014, SEBI imposed a ₹10 lakh penalty each on Thyrocare Diagnostics and Thyrocare Biotech for disclosure norm violations under SAST Regulations.

Market Competition

Thyrocare operates in India's competitive diagnostic services market. Its key peers include Dr. Lal PathLabs Ltd., Metropolis Healthcare Ltd., and Vijaya Diagnostic Centre Ltd., all of which offer a broad spectrum of diagnostic tests and vie for market share across India.

Next Steps

Investors will be closely monitoring Thyrocare's formal response to the Income Tax Department. The outcome of the company's contestation process will be key to resolving this financial demand.